No. of Pages: 160 | Report Code: BMIPUB00032057 | Category: Life Sciences
The North America interventional cardiology devices market size is expected to reach US$ 18,960.93 million by 2033 from US$ 8,511.08 million in 2024. The market is estimated to record a CAGR of 9.5% from 2025 to 2033.
North America is the dominant region in the global interventional cardiology devices market, driven by a high burden of cardiovascular diseases, strong healthcare infrastructure, and early adoption of advanced technologies. The United States leads the region with a high volume of interventional procedures such as angioplasty, stent placement, and transcatheter valve replacements. A well-established network of hospitals and cardiac catheterization labs supports widespread access to minimally invasive treatments. For instance, according to the America Heart Association, as of December 2021, in the United States alone, over 600,000 PCI procedures are performed each year
The region benefits from the presence of leading global device manufacturers, continuous product innovation, and frequent launch of new-generation stents, imaging systems, and transcatheter valves. Favorable reimbursement policies and strong investment in R&D also contribute to market growth. In addition, growing awareness of preventive cardiology and routine screening is leading to earlier diagnosis and higher treatment rates. With high procedure volumes, advanced clinical expertise, and strong regulatory support for device approvals, North America is expected to maintain its leadership in the interventional cardiology market over the coming years
Key segments that contributed to the derivation of the interventional cardiology devices market analysis are product type, material type, application, indication, and end user.
The North American interventional cardiology market is the largest and most mature in the world, with the United States as the dominant player. The region benefits from a high prevalence of cardiovascular diseases, an aging population, and a strong preference for minimally invasive procedures.
A key factor driving this market is the combination of advanced healthcare infrastructure and significant healthcare expenditure. Both the U.S. and Canada have well-established, technologically sophisticated healthcare systems that quickly adopt cutting-edge medical devices. This, coupled with high per capita healthcare spending and favorable reimbursement policies for interventional procedures, creates a robust and stable market that drives the development and commercialization of new technologies.
Based on country, the North America interventional cardiology devices market is segmented into the United States, Canada and Mexico. The United States held the largest share in 2024.
The United States stands as the most developed market for interventional cardiology devices, backed by a highly advanced healthcare ecosystem, widespread adoption of minimally invasive procedures, and a strong base of trained interventional cardiologists. The presence of well-equipped hospitals and catheterization labs ensures the routine performance of interventional procedures across the country. A favorable regulatory and reimbursement landscape encourages the use of newer-generation devices and supports high procedural volumes.
The market is heavily innovation-driven, with continuous technological advancements in areas such as drug-eluting stents, intravascular imaging systems, guidewires, catheters, and atherectomy devices. Adoption of radial access techniques and integration of navigation and imaging technologies into procedural workflows have significantly improved outcomes and procedural efficiency. Overall, the United States offers a mature, highly competitive, and innovation-led environment for interventional cardiology devices. The combination of advanced infrastructure, clinical expertise, and a favorable regulatory climate continues to drive adoption and shape global trends.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 8,511.08 Million |
| Market Size by 2033 | US$ 18,960.93 Million |
| Global CAGR (2025 - 2033) | 9.5% |
| Historical Data | 2022-2023 |
| Forecast period | 2025-2033 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Edwards Lifesciences Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co., Ltd., W. L. Gore & Associates, Inc., and Meril Life Sciences are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The North America Interventional Cardiology Devices Market is valued at US$ 8,511.08 Million in 2024, it is projected to reach US$ 18,960.93 Million by 2033.
As per our report North America Interventional Cardiology Devices Market, the market size is valued at US$ 8,511.08 Million in 2024, projecting it to reach US$ 18,960.93 Million by 2033. This translates to a CAGR of approximately 9.5% during the forecast period.
The North America Interventional Cardiology Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Interventional Cardiology Devices Market report:
The North America Interventional Cardiology Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Interventional Cardiology Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Interventional Cardiology Devices Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Interventional Cardiology Devices Market
